{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:39:23Z","timestamp":1783730363712,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00192-025-06145-7","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:57:09Z","timestamp":1746514629000},"page":"1373-1382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-Term Antibiotics for Disturbed Bladder Microbiome Disorders"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-0490","authenticated-orcid":false,"given":"Yasir","family":"Bukhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Jie","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nucelio","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"6145_CR1","unstructured":"ICS Glossary. ICS. https:\/\/www.ics.org\/glossary\/symptom\/lowerurinarytractsymptomluts. Accessed 4 July 2024."},{"key":"6145_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12941-021-00428-9","volume":"20","author":"HY Lee","year":"2021","unstructured":"Lee HY, Wang J, Juan YS, et al. The impact of urine microbiota in patients with lower urinary tract symptoms. Ann Clin Microbiol Antimicrob. 2021;20:23. https:\/\/doi.org\/10.1186\/s12941-021-00428-9","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"6145_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3934\/microbiol.2017.2.143","volume":"3","author":"J Tang","year":"2017","unstructured":"Tang J. Microbiome in the urinary system\u2014a review. AIMS Microbiol. 2017;3(2):143\u201354. https:\/\/doi.org\/10.3934\/microbiol.2017.2.143","journal-title":"AIMS Microbiol"},{"issue":"9","key":"6145_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00192-013-2325-2","volume":"25","author":"L Brubaker","year":"2014","unstructured":"Brubaker L, Nager CW, Richter HE, et al. Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J. 2014;25(9):1179\u201384. https:\/\/doi.org\/10.1007\/s00192-013-2325-2","journal-title":"Int Urogynecol J"},{"issue":"3","key":"6145_CR5","doi-asserted-by":"publisher","first-page":"347.e1","DOI":"10.1016\/j.ajog.2015.07.009","volume":"213","author":"MM Pearce","year":"2015","unstructured":"Pearce MM, Zilliox MJ, Rosenfeld AB, et al. The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol. 2015;213(3):347.e1-11. https:\/\/doi.org\/10.1016\/j.ajog.2015.07.009","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6145_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4111\/icu.20220357","volume":"64","author":"HW Choi","year":"2023","unstructured":"Choi HW, Lee KW, Kim YH. Microbiome in urological diseases: Axis crosstalk and bladder disorders. Investig Clin Urol. 2023;64(2):126\u201339. https:\/\/doi.org\/10.4111\/icu.20220357","journal-title":"Investig Clin Urol"},{"issue":"10","key":"6145_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1469-0691.2008.02070.x","volume":"14","author":"PC Woo","year":"2008","unstructured":"Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect. 2008;14(10):908\u201334.","journal-title":"Clin Microbiol Infect"},{"key":"6145_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2180-11-244","volume":"11","author":"H Siddiqui","year":"2011","unstructured":"Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 2011;11:244. https:\/\/doi.org\/10.1186\/1471-2180-11-244","journal-title":"BMC Microbiol"},{"issue":"5","key":"6145_CR9","first-page":"1225","volume":"59","author":"R Orenstein","year":"1999","unstructured":"Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician. 1999;59(5):1225\u201334, 1237.","journal-title":"Am Fam Physician"},{"key":"6145_CR10","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/JCM.05852-11","volume":"50","author":"AJ Wolfe","year":"2012","unstructured":"Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50:1376\u201383. https:\/\/doi.org\/10.1128\/JCM.05852-11","journal-title":"J Clin Microbiol"},{"issue":"4","key":"6145_CR11","first-page":"213","volume":"19","author":"M McDonald","year":"2017","unstructured":"McDonald M, Kameh D, Johnson ME, Johansen TE, Albala D, Mouraviev V. A head-to-head comparative phase II study of standard urine culture and sensitivity versus DNA next-generation sequencing testing for urinary tract infections. Rev Urol. 2017;19(4):213.","journal-title":"Rev Urol"},{"issue":"4","key":"6145_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/MOU.0000000000000283","volume":"26","author":"L Cox","year":"2016","unstructured":"Cox L, Rovner ES. Lower urinary tract symptoms in women: epidemiology, diagnosis, and management. Curr Opin Urol. 2016;26(4):328\u201333. https:\/\/doi.org\/10.1097\/MOU.0000000000000283","journal-title":"Curr Opin Urol"},{"issue":"3","key":"6145_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.22037\/uj.v16i7.5976","volume":"18","author":"A JavanBaleghMarand","year":"2021","unstructured":"JavanBaleghMarand A, Van Koeveringe GA, Janssen D, et al. Urinary microbiome and its correlation with disorders of the genitourinary system. Urol J. 2021;18(3):259\u201370. https:\/\/doi.org\/10.22037\/uj.v16i7.5976","journal-title":"Urol J"},{"issue":"1","key":"6145_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.euf.2016.11.001","volume":"4","author":"IM Arag\u00f3n","year":"2018","unstructured":"Arag\u00f3n IM, Herrera-Imbroda B, Queipo-Ortu\u00f1o MI, et al. The urinary tract microbiome in health and disease. Eur Urol Focus. 2018;4(1):128\u201338. https:\/\/doi.org\/10.1016\/j.euf.2016.11.001","journal-title":"Eur Urol Focus"},{"issue":"2","key":"6145_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2053369120936426","volume":"26","author":"A Bhide","year":"2020","unstructured":"Bhide A, Tailor V, Khullar V. Interstitial cystitis\/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome. Post Reprod Health. 2020;26(2):87\u201390. https:\/\/doi.org\/10.1177\/2053369120936426","journal-title":"Post Reprod Health"},{"issue":"1","key":"6145_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","volume":"8","author":"G Berg","year":"2020","unstructured":"Berg G, Rybakova D, Fischer D, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. https:\/\/doi.org\/10.1186\/s40168-020-00875-0","journal-title":"Microbiome"},{"issue":"10","key":"6145_CR17","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.3390\/biomedicines11102816","volume":"11","author":"J Chorbi\u0144ska","year":"2023","unstructured":"Chorbi\u0144ska J, Krajewski W, Nowak \u0141, Ma\u0142kiewicz B, Del Giudice F, Szyde\u0142ko T. Urinary microbiome in bladder diseases\u2014review. Biomedicines. 2023;11(10):2816. https:\/\/doi.org\/10.3390\/biomedicines11102816","journal-title":"Biomedicines"},{"issue":"2","key":"6145_CR18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/ijms23020870","volume":"23","author":"A Kawalec","year":"2022","unstructured":"Kawalec A, Zwoli\u0144ska D. Emerging role of microbiome in the prevention of urinary tract infections in children. Int J Mol Sci. 2022;23(2):870. https:\/\/doi.org\/10.3390\/ijms23020870","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6145_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/JCM.05852-11","volume":"50","author":"AJ Wolfe","year":"2012","unstructured":"Wolfe AJ, Toh E, Shibata N, et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50(4):1376\u201383. https:\/\/doi.org\/10.1128\/JCM.05852-11","journal-title":"J Clin Microbiol"},{"issue":"12","key":"6145_CR20","doi-asserted-by":"publisher","first-page":"e114185","DOI":"10.1371\/journal.pone.0114185","volume":"9","author":"V Nienhouse","year":"2014","unstructured":"Nienhouse V, Gao X, Dong Q, et al. Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity. PLoS ONE. 2014;9(12):e114185. https:\/\/doi.org\/10.1371\/journal.pone.0114185","journal-title":"PLoS ONE"},{"issue":"2","key":"6145_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrurol.2014.361","volume":"12","author":"SA Whiteside","year":"2015","unstructured":"Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract\u2013a role beyond infection. Nat Rev Urol. 2015;12(2):81\u201390. https:\/\/doi.org\/10.1038\/nrurol.2014.361","journal-title":"Nat Rev Urol"},{"issue":"33","key":"6145_CR22","doi-asserted-by":"publisher","first-page":"e2117904119","DOI":"10.1073\/pnas.2117904119","volume":"119","author":"CH Song","year":"2022","unstructured":"Song CH, Kim YH, Naskar M, et al. Lactobacillus crispatus limits bladder uropathogenic E. coli infection by triggering a host type I interferon response. Proc Natl Acad Sci U S A. 2022;119(33):e2117904119. https:\/\/doi.org\/10.1073\/pnas.2117904119","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"6145_CR23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/ijms25031732","volume":"25","author":"N Kustrimovic","year":"2024","unstructured":"Kustrimovic N, Bilato G, Mortara L, Baci D. The urinary microbiome in health and disease: relevance for bladder cancer. Int J Mol Sci. 2024;25(3):1732. https:\/\/doi.org\/10.3390\/ijms25031732","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6145_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11884-019-00543-6","volume":"14","author":"AL Ackerman","year":"2019","unstructured":"Ackerman AL, Chai TC. The bladder is not sterile: an update on the urinary microbiome. Curr Bladder Dysfunct Rep. 2019;14(4):331\u201341. https:\/\/doi.org\/10.1007\/s11884-019-00543-6","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"3","key":"6145_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5213\/inj.2244016.008","volume":"26","author":"S Bae","year":"2022","unstructured":"Bae S, Chung H. The urobiome and its role in overactive bladder. Int Neurourol J. 2022;26(3):190\u2013200. https:\/\/doi.org\/10.5213\/inj.2244016.008","journal-title":"Int Neurourol J"},{"issue":"1","key":"6145_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/nau.25058","volume":"42","author":"MG Mueller","year":"2023","unstructured":"Mueller MG, Das P, Andy U, et al. Characterization of the GU microbiome in women with self-perceived bladder health over the life course. Neurourol Urodyn. 2023;42(1):133\u201345. https:\/\/doi.org\/10.1002\/nau.25058","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"6145_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/AOG.0000000000001892","volume":"129","author":"MG Abernethy","year":"2017","unstructured":"Abernethy MG, Rosenfeld A, White JR, Mueller MG, Lewicky-Gaupp C, Kenton K. Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet Gynecol. 2017;129(3):500\u20136. https:\/\/doi.org\/10.1097\/AOG.0000000000001892","journal-title":"Obstet Gynecol"},{"key":"6145_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1471-2180-12-205","volume":"12","author":"H Siddiqui","year":"2012","unstructured":"Siddiqui H, Lagesen K, Nederbragt AJ, Jeansson SL, Jakobsen KS. Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol. 2012;12:205. https:\/\/doi.org\/10.1186\/1471-2180-12-205","journal-title":"BMC Microbiol"},{"issue":"11","key":"6145_CR29","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/diagnostics13111921","volume":"13","author":"DS Kim","year":"2023","unstructured":"Kim DS, Lee JW. Urinary tract infection and microbiome. Diagnostics (Basel). 2023;13(11):1921. https:\/\/doi.org\/10.3390\/diagnostics13111921","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"6145_CR30","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1017\/ash.2023.507","volume":"3","author":"TD Corse","year":"2023","unstructured":"Corse TD, Rahmani LD, Hasley HL, Kim K, Harrison R, Fromer DL. New avenue of diagnostic stewardship: procedural stewardship for recurrent urinary tract infections in female patients. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e231. https:\/\/doi.org\/10.1017\/ash.2023.507","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"4","key":"6145_CR31","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/nau.23072","volume":"36","author":"R Doggweiler","year":"2017","unstructured":"Doggweiler R, Whitmore KE, Meijlink JM, Drake MJ, Frawley H, Nordling J, Hanno P, Fraser MO, Homma Y, Garrido G, Gomes MJ, Elneil S, van de Merwe JP, Lin ATL, Tomoe H. A standard for terminology in chronic pelvic pain syndromes: a report from the chronic pelvic pain working group of the international continence society. Neurourol Urodyn. 2017;36(4):984\u20131008.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"6145_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mucimm.2022.12.003","volume":"16","author":"CCY Chieng","year":"2023","unstructured":"Chieng CCY, Kong Q, Liou NSY, Khasriya R, Horsley H. The clinical implications of bacterial pathogenesis and mucosal immunity in chronic urinary tract infection. Mucosal Immunol. 2023;16(1):61\u201371. https:\/\/doi.org\/10.1016\/j.mucimm.2022.12.003","journal-title":"Mucosal Immunol"},{"key":"6145_CR33","doi-asserted-by":"publisher","unstructured":"Josephs-Spaulding J, Krogh TJ, Rettig HC, et al. Recurrent Urinary Tract Infections: Unraveling the Complicated Environment of Uncomplicated rUTIs. Front Cell Infect Microbiol. 2021;11. https:\/\/doi.org\/10.3389\/fcimb.2021.562525","DOI":"10.3389\/fcimb.2021.562525"},{"issue":"4","key":"6145_CR34","doi-asserted-by":"publisher","first-page":"e244880","DOI":"10.1001\/jamanetworkopen.2024.4880","volume":"7","author":"SH Shen","year":"2024","unstructured":"Shen SH, Peng L, Zeng X, Zhang J, Shen H, Luo DY. Intravesical interferon therapy vs hyaluronic acid for pain among female individuals with interstitial cystitis: a randomized clinical trial. JAMA Netw Open. 2024;7(4):e244880. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4880","journal-title":"JAMA Netw Open"},{"issue":"3","key":"6145_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/tog.12807","volume":"24","author":"I Offiah","year":"2022","unstructured":"Offiah I, Campbell R, Dua A, Bombieri L, Freeman R. Present status and advances in bladder pain syndrome: central sensitisation and the urinary microbiome. Obstet Gynaecol. 2022;24(3):159\u201366. https:\/\/doi.org\/10.1111\/tog.12807","journal-title":"Obstet Gynaecol"},{"key":"6145_CR36","unstructured":"Diagnosis and Treatment of Interstitial Cystitis\/Bladder Pain Syndrome (2022) - American Urological Association. https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/diagnosis-and-treatment-interstitial-of-cystitis\/bladder-pain-syndrome-(2022). Accessed 6 Aug 2024."},{"issue":"5","key":"6145_CR37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5489\/cuaj.11214","volume":"5","author":"S Dason","year":"2011","unstructured":"Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5(5):316\u201322. https:\/\/doi.org\/10.5489\/cuaj.11214","journal-title":"Can Urol Assoc J"},{"issue":"7","key":"6145_CR38","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00192-018-3569-7","volume":"29","author":"S Swamy","year":"2018","unstructured":"Swamy S, Barcella W, De Iorio M, et al. Recalcitrant chronic bladder pain and recurrent cystitis but negative urinalysis: What should we do? Int Urogynecol J. 2018;29(7):1035\u201343. https:\/\/doi.org\/10.1007\/s00192-018-3569-7","journal-title":"Int Urogynecol J"},{"issue":"5","key":"6145_CR39","doi-asserted-by":"publisher","first-page":"e015233","DOI":"10.1136\/bmjopen-2016-015233","volume":"7","author":"H Ahmed","year":"2017","unstructured":"Ahmed H, Davies F, Francis N, Farewell D, Butler C, Paranjothy S. Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials. BMJ Open. 2017;7(5):e015233. https:\/\/doi.org\/10.1136\/bmjopen-2016-015233","journal-title":"BMJ Open"},{"issue":"6","key":"6145_CR40","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1177\/147323001103900633","volume":"39","author":"YH Zhong","year":"2011","unstructured":"Zhong YH, Fang Y, Zhou JZ, Tang Y, Gong SM, Ding XQ. Effectiveness and safety of patient-initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study. J Int Med Res. 2011;39(6):2335\u201343.","journal-title":"J Int Med Res"},{"key":"6145_CR41","first-page":"1173","volume":"25","author":"E Costantini","year":"2014","unstructured":"Costantini E, Zucchi A, Salvini E, Cicalese A, Li Marzi V, Filocamo MT, Bini V, Lazzeri M. Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial. Int Urogynecol J. 2014;25:1173\u20138.","journal-title":"Int Urogynecol J"},{"key":"6145_CR42","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00345-020-03464-w","volume":"39","author":"NN Maredia","year":"2021","unstructured":"Maredia NN, Fanning MJ, Christie AL, Prokesch BC, Zimmern PE. Adverse effects of chronic nitrofurantoin therapy in women with recurrent urinary tract infections in an outpatient setting. World J Urol. 2021;39:2597\u2013603.","journal-title":"World J Urol"},{"key":"6145_CR43","unstructured":"Urinary Tract Infections in Pregnant Individuals. https:\/\/www.acog.org\/clinical\/clinical-guidance\/clinical-consensus\/articles\/2023\/08\/urinary-tract-infections-in-pregnant-individuals. Accessed 6 Aug 2024."},{"issue":"3","key":"6145_CR44","doi-asserted-by":"publisher","first-page":"CD001209","DOI":"10.1002\/14651858.CD001209.pub2","volume":"2004","author":"X Albert","year":"2004","unstructured":"Albert X, Huertas I, Pereir\u00f3 II, Sanf\u00e9lix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004;2004(3):CD001209. https:\/\/doi.org\/10.1002\/14651858.CD001209.pub2","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"6145_CR45","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0022-5347(05)67520-9","volume":"163","author":"JW Warren","year":"2000","unstructured":"Warren JW, Horne LM, Hebel JR, Marvel RP, Keay SK, Chai TC. Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J Urol. 2000;163(6):1685\u20138.","journal-title":"J Urol"},{"issue":"30","key":"6145_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00192-018-3846-5","volume":"4","author":"S Swamy","year":"2019","unstructured":"Swamy S, Kupelian AS, Khasriya R, Dharmasena D, Toteva H, Dehpour T, Collins L, Rohn JL, Malone-Lee J. Cross-over data supporting long-term antibiotic treatment in patients with painful lower urinary tract symptoms, pyuria and negative urinalysis. Int Urogynecol J. 2019;4(30):409\u201314.","journal-title":"Int Urogynecol J"},{"issue":"7","key":"6145_CR47","first-page":"420","volume":"55","author":"N Rudenko","year":"2005","unstructured":"Rudenko N, Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung. 2005;55(7):420\u20137.","journal-title":"Arzneimittelforschung."}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06145-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06145-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06145-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:22:32Z","timestamp":1757164952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06145-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6145"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06145-7","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}